Association between the Risk Factors and Uterine Fibroids in Reproductive Age Group in Mosul City

Sanaa Ghazi  Mustafa; Asmaa Abdulrazaq  Alsanjary

Sanaa Ghazi Mustafa Master student, University of Mosul, College of Nursing
Asmaa Abdulrazaq Alsanjary Lecturer, University of Mosul, College of Medicine

Keywords: Mosul City

Abstract

The benign tumours known as uterine fibroids (UF), commonly referred to as myomas, develop from the uterus' smooth muscle cells. Age, race, parity, obesity, vitamin D deficiency, and hypertension that are associated. The major goal of the current study is to identify risk factors associated with uterine fibroid among women in Mosul City. the a non-experimental, descriptive cross – sectional study design to accomplish the objectives of the study for the period extended from 16 December, 2022 to the 20March, 2023 at four hospitals in Mosul city. The P-value for Menarche Age Group was 0.012, Family History of UF was 0.049, Subfertility type was 0.035, and for PCOS was 0.011. The study concluded there are association between uterine fibroids and menarche age, family history, subfertility type, and polycystic ovarian syndrome. The study suggests routine ultrasound scanning in women of reproductive age in order to diagnose them quickly and avoid the related complications.

References

1. Banerjee, S., et al., Human Myometrial and Uterine Fibroid Stem Cell-Derived Organoids for Intervening the Pathophysiology of Uterine Fibroid. Reproductive Sciences, 2022. 29(9): p. 2607-2619.
2. Cheng, L.-C., et al., Global, regional, and national burden of uterine fibroids in the last 30 years: Estimates from the 1990 to 2019 Global Burden of Disease Study. Frontiers in Medicine, 2022. 9: p. 1003605.
3. Wang, A., et al., Health care costs and treatment patterns associated with uterine fibroids and heavy menstrual bleeding: A claims analysis. Journal of Women's Health, 2022. 31(6): p. 856-863.
4. Piekos, J.A., et al., Uterine fibroid polygenic risk score (PRS) associates and predicts risk for uterine fibroid. Human genetics, 2022. 141(11): p. 1739-1748.
5. Yang, Q., et al., Comprehensive review of uterine fibroids: developmental origin, pathogenesis, and treatment. Endocrine reviews, 2022. 43(4): p. 678-719.
6. Charifson, M., et al., Why are Black individuals disproportionately burdened with uterine fibroids and how are we examining the disparity? A systematic review. F&S Reviews, 2022.
7. Kumar, C., et al., A study on uterine fibroids effective treatment and associated risks factors in the tertiary care teaching hospital. Cellular, Molecular and Biomedical Reports, 2023. 3(3): p. 137-144.
8. Ulin, M., et al., Uterine fibroids in menopause and perimenopause. Menopause (New York, NY), 2020. 27(2): p. 238.
9. Muawad, R., R. Dabbagh, and Y. Sabr, Association of health and lifestyle factors with uterine fibroids among Saudi women: A case–control study. Journal of Taibah University Medical Sciences, 2022. 17(6): p. 1039-1046.
10. Huang, D., et al., Presence of Fibroids on Transvaginal Ultrasonography in a Community-Based, Diverse Cohort of 996 Reproductive-Age Female Participants. JAMA Network Open, 2023. 6(5): p. e2312701-e2312701.
11. Ciebiera, M., et al., The significance of measuring vitamin D serum levels in women with uterine fibroids. Reproductive Sciences, 2021. 28: p. 2098-2109.